March 20 (Reuters) - Targovax ASA TRVX.OL :
* IMPACT OF CORONA VIRUS (COVID-19) ON TARGOVAX'S OPERATIONS
* UPDATED CLINICAL AND IMMUNE DATA ARE STILL EXPECTED DURING
FIRST
HALF OF 2020
* COMPANY MAINTAINS ITS EFFORT TO PRESENT PRE-CLINICAL DATA
FOR
NEXT GENERATION ONCOS VIRUSES TO SCIENTIFIC COMMUNITY
* ABSTRACT HAS BEEN APPROVED FOR PRESENTATION AT AACR
MEETING,
WHICH FOR NOW HAS BEEN POSTPONED UNTIL LATER IN 2020.
Source text for Eikon: ID:nWkr9Xnk3Y
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))